Abstract: Described are compounds of the formula ##STR1## wherein ##STR2## wherein Z is hydrogen or loweralkyl, R.sub.5 and R.sub.6 may be the same or different and are hydrogen, loweralkyl or together are alkylene of 4 or 5 carbon atoms,R.sub.2 is hydrogen, halo, haloloweralkyl, loweralkyl, loweralkoxy, loweralkylthio or ##STR3## wherein R.sub.5 and R.sub.6 are previously defined, R.sub.3 is hydroxy, alkoxy, branched alkoxy, adamantyloxy, morpholino, amino or amino substituted by loweralkyl or alkylene of 4 or 5 carbon atoms,R.sub.4 is hydrogen or loweralkyl, andX.sub.1 and X.sub.2 are hydrogen, loweralkyl, halo or when substituted on adjacent carbon atoms of the benzene ring form a 1,3-butadienylene linkage, Y is oxygen or sulfur, and pharmaceutically acceptable salts thereof. The compounds are effective as diuretic agents in increasing urinary excretion.
Abstract: A flow control device for regulating the flow of fluid through a flexible tubing wherein a roller is employed with a grooved surface for incrementally controlling the flow of fluid through the tubing. In order to properly orientate the groove of the roller during its path of travel through the clamp body and over the tubing, a flat segment or interrupted surface portion is provided on the roller and an interfering member is provided in the base of the clamp. In addition, and to improve the efficiency of the clamp, additional features such as a relief surface in the roller, centering lugs for the tubing to position it in the clamp body, as well as circumferential ribs on the roller are provided.
Abstract: Radial block copolymers of the butadiene-styrene type are utilized in an uncured state to form a solid golf ball center which has high rebound characteristics as well as various durometers. The golf ball centers containing the radial block copolymers can be formulated to obtain the specific properties desired by a particular manufacturer and can be manufactured at a lower cost than those presently available.
Abstract: It has been found that substituted aminoacetonitriles of the structure ##STR1## wherein X and Y, independently, stand for hydrogen, halogen, loweralkyl, loweralkyloxy, nitro or CF.sub.3 ; R is hydrogen or methyl; and R' is hydrogen or loweralkyl are excellent insect ovicides.
Abstract: A new fortimicin antibiotic, 2-deoxyfortimicin B, intermediates useful in the preparation of the compound, methods of making and using the compound and compositions containing 2-deoxyfortimicin B.
Type:
Grant
Filed:
April 27, 1980
Date of Patent:
March 9, 1982
Assignee:
Abbott Laboratories
Inventors:
Jerry R. Martin, John S. Tadanier, Paulette Collum
Abstract: A high volume filter for use in an I.V. or blood administration set. A double filter unit is formed by folding a length of filter material into two portions to form pocket members with tubular inlets placed in each. These components are then sealed into a length of plastic tubing with an additional tubular member to form a filter unit. In a preferred embodiment, the filter unit is formed integrally with a drip chamber.
Abstract: An elastometer for measuring the mechanical strength of biological gels such as blood or fibrin clots. Thus this device may be used for accessing anticoagulant and fibrinolitic activities, particularly with respect to drug evaluation. The instrument can also be used to study abnormalities in the blood clotting process, i.e. for clinical diagnosis purposes.
Abstract: A new fortimicin antibiotic, 2-deoxyfortimicin B, intermediates useful in the preparation of the compound, methods of making and using the compound and compositions containing 2-deoxyfortimicin B.
Type:
Grant
Filed:
April 27, 1979
Date of Patent:
March 2, 1982
Assignee:
Abbott Laboratories
Inventors:
Jerry R. Martin, John S. Tadanier, Paulette Collum
Abstract: A gravitational flow system for the sequential administration of medical liquids to a patient comprises a primary container connected to a primary tube, a secondary container connected to a secondary tube, and a combined air barrier and liquid sequencing valve which connects them and is in fluid communication with a common tube extending to the patient. A primary flow control device is positioned in the primary flow path and a secondary flow control device is positioned in the secondary flow path. In operation the system dispenses primary liquid unless interrupted by a flow of secondary liquid. In that instance, primary liquid flow is cut off by an air capturing pocket. At the same time, a plurality of air barriers prevent infusion of air into the patient.
Type:
Grant
Filed:
July 14, 1980
Date of Patent:
February 23, 1982
Assignee:
Abbott Laboratories
Inventors:
Joseph N. Genese, Andrew J. Muetterties
Abstract: A container for liquids, preferably sterile liquids comprises a hollow body constructed of plastic material having a plurality of tubular ports integrally formed and extending therefrom. Each port has a quantity of plastic material integrally formed as a diaphragm within the port so as to seal the container. In a preferred embodiment, at least one of the ports has a resealable septum sealed within it. The diaphragm is positioned between the septum and the liquid within the container so as to prevent deterioration of the resealable septum caused by exposure to the liquid. Both the resealable septum and the diaphragm are constructed of a material which is penetrable by a hypodermic needle for use in administering sterile solutions.
Abstract: It has been found that certain 4-substituted 2-hydroxylaminomethyl phenols or their nontoxic pharmaceutically acceptable acid addition salts are excellent diuretic, saluretic and anti-inflammatory agents.
Abstract: An apparatus for measuring the flow of medical liquids within an intravenous solution administration set comprises a primary tube, a secondary tube and a tertiary tube. A constricter mechanism is postiioned in the primary tube proximate the opening to the tertiary tube in order to restrict the flow of liquid therethrough. As a result, a pressure differential is created between the secondary tube and the tertiary tube when liquid flows through the primary tube. At least a portion of the secondary or tertiary tubes are transparent in order to determine the relative position of liquid in the tube. a series of markings on the tubes represent designated rates of flow. Consequently, the relative position of the liquid is used to display the rate of flow within the system.
Abstract: It has been found that dipeptides containing a 3-fluoro-D-alanine N-terminus are powerful antibacterials and produce a highly useful synergistic effect with antibiotics.
Type:
Grant
Filed:
July 3, 1980
Date of Patent:
January 5, 1982
Assignee:
Abbott Laboratories
Inventors:
Daniel T. Chu, Jerry R. Martin, Alford M. Thomas
Abstract: The biocidal activity of N-(2-methyl-1-naphthyl)-maleimide is vastly improved by chelating it with an amine wherein each free hydrogen on each amino group has been replaced by the groups --(CH.sub.2).sub.n COOY wherein n represents 1 or 2 and each Y represents hydrogen, ammonium or an alkali metal cation.
Type:
Grant
Filed:
May 8, 1980
Date of Patent:
December 22, 1981
Assignee:
Abbott Laboratories
Inventors:
Francis W. Arbir, William J. Rizoff, Frank C. Becker
Abstract: The present invention provides 2,8-disubstituted-10-hydroxy-5,5-dimethyl-tetrahydro-and hexahydro-5H-[1]-benzopyrano[4,3-c]pyridines represented by Formulae I-III: ##STR1## wherein: R is selected from the group consisting of C.sub.4 -C.sub.20 straight or branched chain alkyl, C.sub.8 14 C.sub.20 straight or branched chain arylalkyl; n is an integer from 1-4 inclusive; and X is OH, NR.sub.1 R.sub.2, R.sub.1 and R.sub.2 being the same or different members of the group consisting of hydrogen and loweralkyl, and ##STR2## wherein Y is CH.sub.2, S, O or NR.sub.1 ; and the pharmaceutically acceptable salts thereof. The compounds are useful as antihypertensive agents.